Thyroid-associated ophthalmopathy: pathogenesis and clinical management
- 1 January 1995
- journal article
- review article
- Published by Elsevier in Bailliere's Clinical Endocrinology and Metabolism
- Vol. 9 (1) , 115-135
- https://doi.org/10.1016/s0950-351x(95)80867-1
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathyJournal of Clinical Endocrinology & Metabolism, 1994
- Classification of Eye Changes of Graves' DiseaseThyroid®, 1992
- Role of Connective Tissue Autoimmunity in Graves' OphthalmopathyAutoimmunity, 1992
- Retroocular Fibroblasts: Important Effector Cells in Graves' OphthalmopathyThyroid®, 1992
- Use of Corticosteroids to Prevent Progression of Graves' Ophthalmopathy after Radioiodine Therapy for HyperthyroidismNew England Journal of Medicine, 1989
- More on smoking habits and Graves’ ophthalmopathyJournal of Endocrinological Investigation, 1989
- Expression of a novel combination of fast and slow troponin T isoforms in rabbit extraocular musclesJournal of Muscle Research and Cell Motility, 1988
- Human Retroocular Fibroblastsin Vitro: A Model for the Study of Graves' OphthalmopathyJournal of Clinical Endocrinology & Metabolism, 1987
- Antibodies to Porcine Eye Muscle in Patients with Graves’ Ophthalmopathy: Identification of Serum Immunoglobulins Directed Against Unique Determinants by Immunoblotting and Enzyme-Linked Immunosorbent Assay*Journal of Clinical Endocrinology & Metabolism, 1987
- The Somatomedins: Insulin-Like Growth FactorsPublished by Elsevier ,1986